Commercial bioprocessing questions with Pratima Cherukuri, CSO

Scroll Down

In the Nov/Dec issue of European Pharmaceutical Manufacturer, Pratima Cherukuri, Chief Scientific Officer at Genezen answers vital questions surrounding bioprocessing at commercial scale and provides insight into the key challenges involved.

Read the full article here: European Pharmaceutical Manufacturer – Nov/Dec 2021

You may also be interested in...

LVV Approaches to Pseudotyping and Plasmid…

As cell and gene therapies (C>s) continue to provide unprecedented advancements...

Read more

Genezen Announces the Appointment of Steven…

BOSTON, MA and FISHERS, IN. – March 13, 2023 – Genezen,...

Read more

Omar Lamm on Developments in Pharma…

An interview with Omar Lamm discussing his career in pharma, where...

Read more

Featured

Understanding the requirements of viral vector…

Analytical method development, qualification, and validation are an integral part of...

Read more